Skip to main content
Erschienen in: Drug Safety 8/2012

01.08.2012 | Original Research Article

Workshop- and Telephone-Based Interventions to Improve Adverse Drug Reaction Reporting

A Cluster-Randomized Trial in Portugal

verfasst von: Professor Maria Teresa Herdeiro, Inês Ribeiro-Vaz, Mónica Ferreira, Jorge Polónia, Amílcar Falcão, Adolfo Figueiras

Erschienen in: Drug Safety | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Abstract

Background: Spontaneous reporting of adverse drug reactions (ADRs) is the method most widely used by pharmacovigilance systems, with the principal limitation being the physician’s underreporting.
Objective: This study sought to evaluate the results of workshop and telephone-interview interventions designed to improve the quantity and relevance of ADR reporting by physicians.
Methods: A cluster-randomized controlled trial was conducted on 6579 physicians in northern Portugal in 2008. Following randomization, we allocated 1034 physicians to a telephone-interview intervention, 438 to a workshop intervention and the remaining 5107 to the control group. At the workshop, a real clinical case was presented and participants were then asked to report on it by completing the relevant form. In the telephone intervention, participants were asked (i) whether they had ever had any suspicion of ADRs; (ii) whether they had experienced any difficulties in reporting; (iii) whether they remembered the different methods that could be used for reporting purposes; and (iv) whether they attached importance to the individual physician’s role in reporting. We followed up physicians to assess ADR reporting rates to the Northern Pharmacovigilance Centre. In terms of relevance, adverse reactions were classified as serious or unexpected. Statistical analysis was performed on an intention-to-treat basis, and generalized linear mixed models were applied using the penalized quasi-likelihood method. The physicians studied were followed up over a period of 20 months.
Results: Two hundred physicians underwent the educational intervention. Comparison with the control group showed that the workshop intervention increased the spontaneous ADR reporting rate by an average of 4-fold (relative risk [RR] 3.97; 95% CI 3.86, 4.08; p < 0.001) across the 20 months post-intervention. Telephone interviews, in contrast, proved less efficient since they led to no significant difference (p = 0.052) vis-à-vis the control group in ADR reporting (RR 1.02; 95% CI 1.00, 1.04). The effects of the interventions on the reporting rate of serious and high-causality ADRs indicated that the RRs associated with workshops were 6.84 (95% CI 6.69, 6.98; p<0.001) for serious ADRs and 3.58 (95% CI 3.51, 3.66; p<0.001) for high-causality ADRs.
Conclusions: Whereas telephone interventions only increased spontaneous reporting in the first 4 months of follow-up, workshops significantly increased both the quantity and relevance of spontaneous ADR reporting for more than 1 year.
Literatur
1.
Zurück zum Zitat Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993; 27(7–8): 832–40PubMed Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993; 27(7–8): 832–40PubMed
2.
Zurück zum Zitat Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279(15): 1200–5PubMedCrossRef Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279(15): 1200–5PubMedCrossRef
3.
Zurück zum Zitat Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329(7456): 15–9PubMedCrossRef Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329(7456): 15–9PubMedCrossRef
4.
Zurück zum Zitat Lasser KE, Allen PD, Woolhandler SJ, et al. Timing of new black box warnings and withdrawals for prescription medications. JAMA 2002; 287(17): 2215–20PubMedCrossRef Lasser KE, Allen PD, Woolhandler SJ, et al. Timing of new black box warnings and withdrawals for prescription medications. JAMA 2002; 287(17): 2215–20PubMedCrossRef
5.
Zurück zum Zitat Pedros C, Vallano A, Cereza G, et al. An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain. Drug Saf 2009; 32(1): 77–83PubMedCrossRef Pedros C, Vallano A, Cereza G, et al. An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain. Drug Saf 2009; 32(1): 77–83PubMedCrossRef
6.
Zurück zum Zitat Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006; 29(5): 385–96PubMedCrossRef Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006; 29(5): 385–96PubMedCrossRef
7.
Zurück zum Zitat Herdeiro MT, Figueiras A, Polonia J, et al. Physicians’ attitudes and adverse drug reaction reporting: a case-control study in Portugal. Drug Saf 2005; 28(9): 825–33PubMedCrossRef Herdeiro MT, Figueiras A, Polonia J, et al. Physicians’ attitudes and adverse drug reaction reporting: a case-control study in Portugal. Drug Saf 2005; 28(9): 825–33PubMedCrossRef
8.
Zurück zum Zitat Inman WHW. Assessment drug safety problems. In: Gent M, Shigmatsu I, editors. Epidemiological issues in reported drug-induced illnesses. Honolulu, Ontario: McMaster University Library Press, 1976: 17–24 Inman WHW. Assessment drug safety problems. In: Gent M, Shigmatsu I, editors. Epidemiological issues in reported drug-induced illnesses. Honolulu, Ontario: McMaster University Library Press, 1976: 17–24
9.
Zurück zum Zitat Smith CC, Bennett PM, Pearce HM, et al. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol 1996; 42(4): 423–9PubMedCrossRef Smith CC, Bennett PM, Pearce HM, et al. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol 1996; 42(4): 423–9PubMedCrossRef
10.
Zurück zum Zitat Herdeiro MT, Figueiras A, Polonia J, et al. Influence of pharmacists’ attitudes on adverse drug reaction reporting: a case-control study in Portugal. Drug Saf 2006; 29(4): 331–40PubMedCrossRef Herdeiro MT, Figueiras A, Polonia J, et al. Influence of pharmacists’ attitudes on adverse drug reaction reporting: a case-control study in Portugal. Drug Saf 2006; 29(4): 331–40PubMedCrossRef
11.
Zurück zum Zitat Herdeiro MT, Polonia J, Gestal-Otero JJ, et al. Factors that influence spontaneous reporting of adverse drug reactions: a model centralized in the medical professional. J Eval Clin Pract 2004; 10(4): 483–9PubMedCrossRef Herdeiro MT, Polonia J, Gestal-Otero JJ, et al. Factors that influence spontaneous reporting of adverse drug reactions: a model centralized in the medical professional. J Eval Clin Pract 2004; 10(4): 483–9PubMedCrossRef
12.
Zurück zum Zitat Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf 2009; 32(1): 19–31PubMedCrossRef Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf 2009; 32(1): 19–31PubMedCrossRef
13.
Zurück zum Zitat Figueiras A, Herdeiro MT, Polonia J, et al. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA 2006; 296(9): 1086–93PubMedCrossRef Figueiras A, Herdeiro MT, Polonia J, et al. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA 2006; 296(9): 1086–93PubMedCrossRef
15.
Zurück zum Zitat Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 1999; 319(7211): 670–4PubMedCrossRef Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 1999; 319(7211): 670–4PubMedCrossRef
16.
Zurück zum Zitat Pinheiro JC, Bates DM. Mixed-effects models in S and S-PLUS. 3rd ed. New York: Springer, 2006 Pinheiro JC, Bates DM. Mixed-effects models in S and S-PLUS. 3rd ed. New York: Springer, 2006
17.
Zurück zum Zitat Vorcewest TE, Barstow L, Butcher B. System for voluntary reporting of adverse drug-reactions in a university hospital. Am J Hosp Pharm 1989; 46(11): 2300–3 Vorcewest TE, Barstow L, Butcher B. System for voluntary reporting of adverse drug-reactions in a university hospital. Am J Hosp Pharm 1989; 46(11): 2300–3
18.
Zurück zum Zitat Sivaram C, Johnson S, Tirmizi SN, et al. Morning report: a forum for reporting adverse drug reactions. Jt Comm J Qual Improv 1996; 22(4): 259–63PubMed Sivaram C, Johnson S, Tirmizi SN, et al. Morning report: a forum for reporting adverse drug reactions. Jt Comm J Qual Improv 1996; 22(4): 259–63PubMed
19.
Zurück zum Zitat Castel JM, Figueras A, Pedros C, et al. Stimulating adverse drug reaction reporting: effect of a drug safety bulletin and of including yellow cards in prescription pads. Drug Saf 2003; 26(14): 1049–55PubMedCrossRef Castel JM, Figueras A, Pedros C, et al. Stimulating adverse drug reaction reporting: effect of a drug safety bulletin and of including yellow cards in prescription pads. Drug Saf 2003; 26(14): 1049–55PubMedCrossRef
20.
Zurück zum Zitat McGettigan P, Golden J, Conroy RM, et al. Reporting of adverse drug reactions by hospital doctors and the response to intervention. Br J Clin Pharmacol 1997; 44: 98–100PubMedCrossRef McGettigan P, Golden J, Conroy RM, et al. Reporting of adverse drug reactions by hospital doctors and the response to intervention. Br J Clin Pharmacol 1997; 44: 98–100PubMedCrossRef
21.
Zurück zum Zitat Backstrom M, Mjorndal T. A small economic inducement to stimulate increased reporting of adverse drug reactions: a way of dealing with an old problem? Eur J Clin Pharmacol 2006; 62: 381–5PubMedCrossRef Backstrom M, Mjorndal T. A small economic inducement to stimulate increased reporting of adverse drug reactions: a way of dealing with an old problem? Eur J Clin Pharmacol 2006; 62: 381–5PubMedCrossRef
22.
Zurück zum Zitat Gilroy GW, Scollins MJ, Gay CA, et al. Pharmacy-coordinated program that encourages physician reporting of adverse drug reactions. Am J Hosp Pharm 1990; 47: 1327–33PubMed Gilroy GW, Scollins MJ, Gay CA, et al. Pharmacy-coordinated program that encourages physician reporting of adverse drug reactions. Am J Hosp Pharm 1990; 47: 1327–33PubMed
23.
Zurück zum Zitat Gony M, Badie K, Sommet A, et al. Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrenees region (Pharmaco-MIP) network 2-year pilot study. Drug Saf 2010; 33(5): 409–16PubMedCrossRef Gony M, Badie K, Sommet A, et al. Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrenees region (Pharmaco-MIP) network 2-year pilot study. Drug Saf 2010; 33(5): 409–16PubMedCrossRef
24.
Zurück zum Zitat Scott HD, Thacher-Renshaw A, Rosenbaum SE, et al. Physician reporting of adverse drug reactions: results of the Rhode Island adverse drug reaction reporting project. JAMA 1990; 263(13): 1785–8PubMedCrossRef Scott HD, Thacher-Renshaw A, Rosenbaum SE, et al. Physician reporting of adverse drug reactions: results of the Rhode Island adverse drug reaction reporting project. JAMA 1990; 263(13): 1785–8PubMedCrossRef
25.
Zurück zum Zitat Thomson O’Brien MA, Freemantle N, Oxman AD, et al. Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2001: (2): CD003030 Thomson O’Brien MA, Freemantle N, Oxman AD, et al. Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2001: (2): CD003030
26.
Zurück zum Zitat Davis D, O’Brien MA, Freemantle N, et al. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?. JAMA 1999; 282(9): 867–74PubMedCrossRef Davis D, O’Brien MA, Freemantle N, et al. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?. JAMA 1999; 282(9): 867–74PubMedCrossRef
27.
Zurück zum Zitat Davis D, Thomson M, Oxman A, et al. Changing physicians performance: a systematic review of the effect of continuing medical education strategies. JAMA 1995; 274(9): 700–5PubMedCrossRef Davis D, Thomson M, Oxman A, et al. Changing physicians performance: a systematic review of the effect of continuing medical education strategies. JAMA 1995; 274(9): 700–5PubMedCrossRef
28.
Zurück zum Zitat Thomson O’Brien MA, Oxman AD, Davis DA, et al. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2000; (2): CD000409 Thomson O’Brien MA, Oxman AD, Davis DA, et al. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2000; (2): CD000409
29.
Zurück zum Zitat Figueiras A, Sastre I, Tato F, et al. One-to-one versus group sessions to improve prescription in primary care: a pragmatic randomized controlled trial. Med Care 2001; 39(2): 158–67PubMedCrossRef Figueiras A, Sastre I, Tato F, et al. One-to-one versus group sessions to improve prescription in primary care: a pragmatic randomized controlled trial. Med Care 2001; 39(2): 158–67PubMedCrossRef
30.
Zurück zum Zitat Ribeiro-Vaz I, Herdeiro MT, Polonia J, et al. Strategies to increase the sensitivity of pharmacovigilance in Portugal. Rev Saude Publica 2010; 45(1): 129–35PubMedCrossRef Ribeiro-Vaz I, Herdeiro MT, Polonia J, et al. Strategies to increase the sensitivity of pharmacovigilance in Portugal. Rev Saude Publica 2010; 45(1): 129–35PubMedCrossRef
Metadaten
Titel
Workshop- and Telephone-Based Interventions to Improve Adverse Drug Reaction Reporting
A Cluster-Randomized Trial in Portugal
verfasst von
Professor Maria Teresa Herdeiro
Inês Ribeiro-Vaz
Mónica Ferreira
Jorge Polónia
Amílcar Falcão
Adolfo Figueiras
Publikationsdatum
01.08.2012
Verlag
Springer International Publishing
Erschienen in
Drug Safety / Ausgabe 8/2012
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI
https://doi.org/10.1007/BF03261962

Weitere Artikel der Ausgabe 8/2012

Drug Safety 8/2012 Zur Ausgabe